Glecaprevir and Pibrentasvir

DRUG3 trials

Sponsors

National Taiwan University Hospital, Massachusetts General Hospital, Weill Medical College of Cornell University

Conditions

Hepatitis CKidney Disease, ChronicKidney FailureRenal DiseaseViral Hepatitis C

Phase 4

QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir

TerminatedNCT04515797

Massachusetts General HospitalHepatitis C, Kidney Disease, Chronic, Kidney Failure

Start: 2021-05-01End: 2023-08-31Updated: 2024-12-03

HCV Test and Treat Utilizing Simplified HCV Patient Education

TerminatedNCT05582681

Weill Medical College of Cornell UniversityHepatitis C

Start: 2022-11-11End: 2024-11-22Updated: 2025-02-27

Unknown Phase

eGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAs

CompletedNCT04047680

National Taiwan University HospitalHepatitis C, Renal Disease, Viral Hepatitis C

Start: 2015-02-28End: 2019-06-30Updated: 2019-08-08

Related Papers

Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals.

2019-11-2933 citations